Want to see IN:VIJAYA full AI Analyst Report?
VIJAYA Stock Chart & Stats
₹1313.00
₹36.90(2.81%)
At close: 4:00 PM EDT
₹1313.00
₹36.90(2.81%)
Day’s Range― - ―
52-Week Range₹847.90 - ₹1,545.55
Previous CloseN/A
Volume84.81K
Average Volume (3M)7.14K
Market Cap
₹154.86B
Enterprise Value₹104.05K
Total Cash (Recent Filing)₹2.89B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)81.3
Beta0.71
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.14%
Share Statistics
EPS (TTM)18.23
Shares Outstanding102,997,720
10 Day Avg. Volume16,300
30 Day Avg. Volume7,139
Financial Highlights & Ratios
PEG Ratio2.57
Price to Book (P/B)9.51
Price to Sales (P/S)11.18
P/FCF Ratio103.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,400.00Price Target Upside6.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)22.47
Revenue Forecast (FY)₹9.85B
Bulls Say, Bears Say
Bulls Say
Revenue Growth And ProfitabilityRevenue growth accelerated to 11.32% in 2026 while net margin stayed near 21% and EBITDA margin remained low-to-mid 40s. This indicates the diagnostics model is scaling without losing profitability, supporting durable earnings growth.
Strong Operating Cash GenerationOperating cash flow was 1.4x–2.9x net income across years, providing evidence that reported profits are supported by cash generation. This strengthens funding capacity for laboratory expansion, equipment and routine operations without relying solely on external capital.
Moderate LeverageDebt-to-equity remained about 0.40–0.45 while equity expanded with assets, and prior returns on equity were solid. Moderate leverage gives the diagnostic network financial flexibility to invest through the medium term, despite some cooling in returns.
Bears Say
Uneven Free Cash Flow ConversionFree cash flow conversion ranged from roughly 24% to 75% of net income and fell to about 32% in 2026. Variability means capital spending or working-capital needs can absorb earnings, reducing predictability of internally available expansion cash.
Rising Absolute DebtAbsolute debt increased in 2026 versus 2025 even though leverage remained moderate. If growth slows, higher obligations could increase financing sensitivity and constrain investment flexibility, making balance-sheet discipline important as the network expands.
Gross Margin VolatilityGross margin dropped sharply in 2023 before recovering, pointing to volatility in costs or service mix. Although later profitability was strong, a repeat could pressure earnings quality and make long-term margin sustainability less predictable.
Vijaya Diagnostic Centre Ltd. News
VIJAYA FAQ
What was Vijaya Diagnostic Centre Ltd.’s price range in the past 12 months?
Vijaya Diagnostic Centre Ltd. lowest stock price was ₹847.90 and its highest was ₹1545.55 in the past 12 months.
What is Vijaya Diagnostic Centre Ltd.’s market cap?
Vijaya Diagnostic Centre Ltd.’s market cap is ₹154.86B.
When is Vijaya Diagnostic Centre Ltd.’s upcoming earnings report date?
Vijaya Diagnostic Centre Ltd.’s upcoming earnings report date is Nov 05, 2026 which is in 71 days.
How were Vijaya Diagnostic Centre Ltd.’s earnings last quarter?
Vijaya Diagnostic Centre Ltd. released its earnings results on Aug 06, 2026. The company reported ₹5.2 earnings per share for the quarter, beating the consensus estimate of ₹4.508 by ₹0.692.
Is Vijaya Diagnostic Centre Ltd. overvalued?
According to Wall Street analysts Vijaya Diagnostic Centre Ltd.’s price is currently Undervalued.
Does Vijaya Diagnostic Centre Ltd. pay dividends?
Vijaya Diagnostic Centre Ltd. pays a Annually dividend of ₹2 which represents an annual dividend yield of 0.14%. See more information on Vijaya Diagnostic Centre Ltd. dividends here
What is Vijaya Diagnostic Centre Ltd.’s EPS estimate?
Vijaya Diagnostic Centre Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vijaya Diagnostic Centre Ltd. have?
Vijaya Diagnostic Centre Ltd. has 102,997,720 shares outstanding.
What happened to Vijaya Diagnostic Centre Ltd.’s price movement after its last earnings report?
Vijaya Diagnostic Centre Ltd. reported an EPS of ₹5.2 in its last earnings report, beating expectations of ₹4.508. Following the earnings report the stock price went down -1.684%.
Which hedge fund is a major shareholder of Vijaya Diagnostic Centre Ltd.?
Currently, no hedge funds are holding shares in IN:VIJAYA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vijaya Diagnostic Centre Ltd.
Vijaya Diagnostic Centre Limited delivers a broad spectrum of diagnostic services to patients across India. Its extensive laboratory offerings include clinical biochemistry, haematology (and immune-haematology), clinical pathology, histopathology, cytopathology, microbiology, serology, cytogenetics, and molecular pathology. For imaging, the company provides advanced radiology services such as magnetic resonance imaging (MRI), multi-slice CT, 3D dental CBCT, mammography, DEXA/bone densitometry, ultrasound with color doppler, nuclear medicine including PET/CT, and digital X-rays. Beyond these, specialized services cover cardiology, neurology, and gastroenterology. The center also offers health check-up packages and convenient home sample collection. Headquartered in Hyderabad, India, and founded in 1981, Vijaya Diagnostic Centre operates a significant network of 80 diagnostic centers and 11 reference laboratories. These facilities are spread across 13 cities and towns, primarily in Telangana and Andhra Pradesh, alongside the National Capital Region and Kolkata.
VIJAYA Stock 12 Month Forecast
Average Price Target
₹1,400.00
▲(6.63% Upside)
Technical Analysis
Krsnaa Diagnostics Limited
―
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Suraksha Diagnostic Ltd.
―
Thyrocare Technologies Ltd
―







